Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.03
AMS's Cash to Debt is ranked lower than
52% of the 350 Companies
in the Global Medical Care industry.

( Industry Median: 0.20 vs. AMS: 0.03 )
AMS' s 10-Year Cash to Debt Range
Min: 0   Max: 1.04
Current: 0.03

0
1.04
Equity to Asset 0.32
AMS's Equity to Asset is ranked higher than
60% of the 334 Companies
in the Global Medical Care industry.

( Industry Median: 0.42 vs. AMS: 0.32 )
AMS' s 10-Year Equity to Asset Range
Min: -0.34   Max: 0.41
Current: 0.32

-0.34
0.41
F-Score: 4
Z-Score: 0.56
M-Score: -3.46
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -0.32
AMS's Operating margin (%) is ranked higher than
53% of the 350 Companies
in the Global Medical Care industry.

( Industry Median: 9.21 vs. AMS: -0.32 )
AMS' s 10-Year Operating margin (%) Range
Min: -20.53   Max: 45.83
Current: -0.32

-20.53
45.83
Net-margin (%) -6.18
AMS's Net-margin (%) is ranked higher than
53% of the 350 Companies
in the Global Medical Care industry.

( Industry Median: 4.59 vs. AMS: -6.18 )
AMS' s 10-Year Net-margin (%) Range
Min: -6.18   Max: 57.1
Current: -6.18

-6.18
57.1
ROE (%) -4.67
AMS's ROE (%) is ranked higher than
54% of the 331 Companies
in the Global Medical Care industry.

( Industry Median: 11.00 vs. AMS: -4.67 )
AMS' s 10-Year ROE (%) Range
Min: -4.64   Max: 1872.38
Current: -4.67

-4.64
1872.38
ROA (%) -1.41
AMS's ROA (%) is ranked higher than
57% of the 356 Companies
in the Global Medical Care industry.

( Industry Median: 4.18 vs. AMS: -1.41 )
AMS' s 10-Year ROA (%) Range
Min: -1.37   Max: 70.39
Current: -1.41

-1.37
70.39
ROC (Joel Greenblatt) (%) -0.09
AMS's ROC (Joel Greenblatt) (%) is ranked higher than
54% of the 353 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. AMS: -0.09 )
AMS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -0.09   Max: 28.46
Current: -0.09

-0.09
28.46
Revenue Growth (3Y)(%) -14.00
AMS's Revenue Growth (3Y)(%) is ranked higher than
50% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. AMS: -14.00 )
AMS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -44.3   Max: 27.8
Current: -14

-44.3
27.8
EBITDA Growth (3Y)(%) -12.10
AMS's EBITDA Growth (3Y)(%) is ranked higher than
53% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. AMS: -12.10 )
AMS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -34.3   Max: 124.1
Current: -12.1

-34.3
124.1
» AMS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with AMS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.70
AMS's P/B is ranked higher than
98% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 3.80 vs. AMS: 0.70 )
AMS' s 10-Year P/B Range
Min: 0.26   Max: 1.99
Current: 0.7

0.26
1.99
P/S 0.90
AMS's P/S is ranked higher than
81% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 2.00 vs. AMS: 0.90 )
AMS' s 10-Year P/S Range
Min: 0.24   Max: 2.02
Current: 0.9

0.24
2.02
PFCF 7.20
AMS's PFCF is ranked higher than
96% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 141.88 vs. AMS: 7.20 )
AMS' s 10-Year PFCF Range
Min: 0.86   Max: 56
Current: 7.2

0.86
56
POCF 2.05
AMS's POCF is ranked higher than
99% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 22.00 vs. AMS: 2.05 )
AMS' s 10-Year POCF Range
Min: 0.59   Max: 4.56
Current: 2.05

0.59
4.56
Current Ratio 0.88
AMS's Current Ratio is ranked higher than
58% of the 337 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. AMS: 0.88 )
AMS' s 10-Year Current Ratio Range
Min: 0.42   Max: 4.12
Current: 0.88

0.42
4.12
Quick Ratio 0.88
AMS's Quick Ratio is ranked higher than
61% of the 337 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. AMS: 0.88 )
AMS' s 10-Year Quick Ratio Range
Min: 0.42   Max: 4.12
Current: 0.88

0.42
4.12
Days Sales Outstanding 75.57
AMS's Days Sales Outstanding is ranked higher than
61% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 54.36 vs. AMS: 75.57 )
AMS' s 10-Year Days Sales Outstanding Range
Min: 13.48   Max: 93.87
Current: 75.57

13.48
93.87

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 0.70
AMS's Price/Tangible Book is ranked higher than
98% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 16.70 vs. AMS: 0.70 )
AMS' s 10-Year Price/Tangible Book Range
Min: 0.27   Max: 2.45
Current: 0.7

0.27
2.45
Price/DCF (Projected) 0.30
AMS's Price/DCF (Projected) is ranked higher than
100% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMS: 0.30 )
AMS' s 10-Year Price/DCF (Projected) Range
Min: 0.21   Max: 0.81
Current: 0.3

0.21
0.81
Price/Median PS Value 1.10
AMS's Price/Median PS Value is ranked higher than
81% of the 408 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. AMS: 1.10 )
AMS' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 4.21
Current: 1.1

0.2
4.21
Earnings Yield (Greenblatt) -0.10
AMS's Earnings Yield (Greenblatt) is ranked higher than
52% of the 345 Companies
in the Global Medical Care industry.

( Industry Median: 4.30 vs. AMS: -0.10 )
AMS' s 10-Year Earnings Yield (Greenblatt) Range
Min: -0.1   Max: 9.9
Current: -0.1

-0.1
9.9
Forward Rate of Return (Yacktman) 20.72
AMS's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 11.83 vs. AMS: 20.72 )
AMS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 1.6   Max: 56.7
Current: 20.72

1.6
56.7

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:AZS.Germany,
American Shared Hospital Services was incorporated in the State of California in 1983 and its predecessor, Ernest A. Bates, M.D., Ltd. (d/b/a American Shared Hospital Services), a California limited partnership, was formed in June 1980. It provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to seventeen (17) medical centers in sixteen (16) states in the United States and two medical centers in Turkey, as of March 1, 2013. The Gamma Knife stereotactic radiosurgery is a non-invasive procedure and an alternative to conventional brain surgery or can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually involves shorter patient hospitalization, lower risk of complications and can be provided at a lower cost. Typically, Gamma Knife patients resume their pre-surgical activities one or two days after treatment. The Gamma Knife treats patients with 201 single doses of gamma rays that are focused with great precision on small and medium sized, well circumscribed and critically located structures in the brain. During 2006 Elekta introduced a new Gamma Knife model, the Perfexion unit, which treats patients with 192 single doses of gamma rays and will also provide the ability to perform procedures on areas of the upper cervical spine. The Gamma Knife delivers a concentrated dose of gamma rays from Cobalt-60 sources housed in the Gamma Knife. The Cobalt-60 sources converge at the target area and deliver a dose that is high enough to destroy the diseased tissue without damaging surrounding healthy tissue. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). Research is being conducted to determine whether the Gamma Knife can be effective in the treatment of epilepsy and other functional disorders. Conventional neurosurgery, radiation therapy and other radiosurgery devices are the primary competitors of Gamma Knife radiosurgery. The Medicare program is administered by the Centers for Medicare and Medicaid Services of the U.S. Department of Health and Human Services.
» More Articles for AMS

Headlines

Articles On GuruFocus.com
American Shared Hospital Services: Can a Gamma Knife Generate Alpha? Apr 30 2012 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 15 2010 
American Shared Hospital Services (AMS) CHAIRMAN AND CEO, 10% Owner Shared Hospital Services America Sep 14 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 16 2010 
American Shared Hospital Services Reports Operating Results (10-Q) May 17 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 16 2009 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 14 2009 
American Shared Hospital Services Reports Operating Results (10-Q) May 15 2009 

More From Other Websites
10-K for American Shared Hospital Services Apr 24 2015
AMSC Prices Offering of Common Stock Apr 24 2015
UPDATE 2-Listing preferred option for Anglo's South Africa platinum mines- CEO Apr 24 2015
AMSC Provides Preliminary Financial Results Apr 23 2015
AMSC Announces Proposed Public Offering of Common Stock Apr 23 2015
Listing preferred option for Anglo's South Africa platinum mines- CEO Apr 23 2015
AMSC Provides Update on Sinovel Litigation Apr 23 2015
Eversource Energy Joins the Homeland Security Resilient Electric Grid Utility Group Apr 22 2015
AMSC Announces U.S. Navy's Intention to Order High Temperature Superconductor (HTS) Equipment Apr 20 2015
ams’ unveils specialty sensor technology portfolio optimized for IoT applications Apr 15 2015
AMSC Congratulates Customer Inox Wind on Successful IPO Apr 09 2015
AMERICAN SHARED HOSPITAL SERVICES Financials Apr 07 2015
American Shared Hospital Services Announces Annual Meeting Date Apr 06 2015
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 8-K, Other Events Apr 01 2015
American Shared Hospital Services Provides Update on Form 10-K Apr 01 2015
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 30 2015
American Shared Hospital Services Reports Fourth Quarter and 2014 Results Mar 30 2015
Q4 2014 American Shared Hospital Services Earnings Release - Time Not Supplied Mar 30 2015
American Shared Hospital Services Announces Fourth Quarter 2014 and Year End Results Earnings... Mar 26 2015
AMSC Announces Reverse Stock Split Mar 24 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK